| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 334.18M | 510.67M | 502.40M | 640.31M | 544.48M | 60.32M |
| Gross Profit | 21.78M | 121.07M | 123.46M | 8.40M | 238.86M | 9.39M |
| EBITDA | -383.15M | -1.16B | -63.12M | -1.84B | 140.79M | 1.63M |
| Net Income | -768.31M | -1.32B | -246.49M | -2.15B | 47.31M | -12.21M |
Balance Sheet | ||||||
| Total Assets | 2.30B | 1.60B | 712.16M | 807.69M | 2.44B | 225.58M |
| Cash, Cash Equivalents and Short-Term Investments | 453.44M | 836.20M | 50.41M | 15.88M | 117.87M | 8.67M |
| Total Debt | 1.06B | 1.20B | 865.54M | 37.73M | 818.81M | 40.29M |
| Total Liabilities | 3.42B | 2.42B | 1.31B | 1.22B | 1.10B | 91.88M |
| Stockholders Equity | -1.13B | -820.18M | -596.94M | -409.35M | 1.34B | 133.70M |
Cash Flow | ||||||
| Free Cash Flow | -354.09M | -52.06M | 48.95M | -396.47M | -116.01M | -25.33M |
| Operating Cash Flow | 138.99M | 42.90M | 65.11M | 205.19M | -56.73M | -23.77M |
| Investing Cash Flow | -496.22M | -95.19M | -3.00M | -590.78M | -423.84M | -15.14M |
| Financing Cash Flow | 556.88M | 819.57M | -44.65M | 306.15M | 603.53M | 40.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $3.80B | 25.03 | 32.78% | ― | 22.02% | 12.42% | |
75 Outperform | $3.09B | 7.25 | 14.28% | 1.37% | 0.58% | 5.76% | |
69 Neutral | $1.94B | 28.73 | 9.79% | ― | 10.58% | -45.52% | |
68 Neutral | $2.94B | 34.94 | 9.51% | ― | 19.28% | 6.16% | |
66 Neutral | $3.09B | 10.70 | 23.10% | ― | 7.25% | -1.12% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
41 Neutral | $4.77B | 110.48 | ― | ― | -40.08% | ― |
On October 30, 2025, Core Scientific held a special meeting of stockholders to consider the merger with CoreWeave, Inc., but the proposal did not receive the necessary approval from stockholders. Consequently, Core Scientific terminated the Merger Agreement on the same day, impacting its strategic plans and future operations.
The most recent analyst rating on (CORZ) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.
Core Scientific, Inc. announced plans to present an investor presentation on or after October 30, 2025, highlighting its strategic growth and expansion in the digital infrastructure sector. The company is on track to energize 250 MW by the end of 2025 and 590 MW by early 2027, with significant contracts such as a 12-year agreement with CoreWeave valued at over $10 billion. This expansion is expected to strengthen Core Scientific’s market position and provide substantial economic benefits, with anticipated profit margins of 75% to 80%.
The most recent analyst rating on (CORZ) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.
On October 30, 2025, Core Scientific announced the termination of its merger agreement with CoreWeave due to insufficient stockholder votes. The company will continue to operate as a publicly traded entity on Nasdaq under the ticker symbol CORZ, maintaining its focus on digital infrastructure and high-density colocation services.
The most recent analyst rating on (CORZ) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.
On October 30, 2025, Core Scientific announced that its stockholders did not approve the proposed merger agreement with CoreWeave, Inc. during a special meeting held on the same day. This outcome may impact Core Scientific’s strategic plans and its positioning within the digital infrastructure industry, affecting stakeholders and potentially altering the company’s future operational focus.
The most recent analyst rating on (CORZ) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.
Core Scientific, Inc., a leader in digital infrastructure for high-density colocation services and digital asset mining, operates dedicated facilities to provide digital infrastructure and software solutions to third-party customers.
Core Scientific, Inc. reported its fiscal third quarter 2025 results, showing a decline in total revenue to $81.1 million from $95.4 million in the previous year. The company experienced a decrease in digital asset self-mining and hosted mining revenues, offset by an increase in high-density colocation revenue. Despite a net loss of $146.7 million, this was an improvement from the previous year’s loss due to smaller fair value adjustments. The company is also involved in a pending merger with CoreWeave, which would result in an all-stock transaction, subject to shareholder approval.
The most recent analyst rating on (CORZ) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.
On July 7, 2025, Core Scientific, Inc. announced a merger with CoreWeave, Inc., where Core Scientific will become a wholly owned subsidiary of CoreWeave. This merger has led to legal challenges from some stockholders who allege disclosure deficiencies in the merger’s proxy statement/prospectus. Despite these allegations, Core Scientific and CoreWeave plan to supplement their disclosures to address these concerns, although they deny any legal necessity for additional disclosures.
The most recent analyst rating on (CORZ) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.
Core Scientific, Inc. announced an updated investor presentation related to a proposed merger with CoreWeave, Inc., scheduled for a stockholder vote on October 30, 2025. The merger is expected to provide significant benefits, including risk reduction in data center delivery, a premium exchange ratio, and a substantial ownership stake in a leading AI platform. The merger aims to enhance Core Scientific’s market position by capitalizing on synergies and cost savings, while also expanding its addressable market in the AI infrastructure sector.
The most recent analyst rating on (CORZ) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.